Rep. Gilbert Ray Cisneros, Jr. Purchases National Health Investors, Inc. (NYSE:NHI) Shares

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of National Health Investors, Inc. (NYSE:NHI). In a filing disclosed on September 04th, the Representative disclosed that they had bought between $1,001 and $15,000 in National Health Investors stock on July 10th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Mesabi Trust (NYSE:MSB) on 7/31/2026.
• Purchased $1,001 – $15,000 in shares of Praxis Precision Medicines (NASDAQ:PRAX) on 7/30/2026.
• Purchased $15,001 – $50,000 in shares of Alkermes (NASDAQ:ALKS) on 7/30/2026.
• Sold $15,001 – $50,000 in shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 7/30/2026.
• Sold $100,001 – $250,000 in shares of Alibaba Group (NYSE:BABA) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Adobe (NASDAQ:ADBE) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Viavi Solutions (NASDAQ:VIAV) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of SailPoint (NASDAQ:SAIL) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of Glacier Bancorp (NYSE:GBCI) on 7/21/2026.
• Sold $1,001 – $15,000 in shares of FedEx (NYSE:FDX) on 7/21/2026.

National Health Investors Trading Up 0.7%

Shares of NHI stock traded up $0.47 on Tuesday, reaching $71.35. 338,872 shares of the company’s stock were exchanged, compared to its average volume of 423,430. National Health Investors, Inc. has a 52 week low of $67.94 and a 52 week high of $91.38. The stock has a market capitalization of $3.50 billion, a PE ratio of 20.62, a P/E/G ratio of 3.78 and a beta of 0.52. The company’s fifty day simple moving average is $75.25 and its 200 day simple moving average is $77.98. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. The business had revenue of $121.32 million for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The business’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.22 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, analysts forecast that National Health Investors, Inc. will post 4.76 EPS for the current year.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be given a $0.92 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a yield of 5.2%. National Health Investors’s dividend payout ratio (DPR) is currently 108.67%.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Zacks Research lowered shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. BMO Capital Markets dropped their price target on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday, June 15th. Weiss Ratings lowered National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Wells Fargo & Company cut their price target on shares of National Health Investors from $79.00 to $78.00 and set an “equal weight” rating for the company in a report on Tuesday, September 1st. Finally, Truist Financial decreased their price objective on shares of National Health Investors from $81.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, September 2nd. Five analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, National Health Investors presently has a consensus rating of “Moderate Buy” and a consensus price target of $83.57.

Hedge Funds Weigh In On National Health Investors

Hedge funds have recently bought and sold shares of the company. BlackRock Inc. bought a new stake in National Health Investors in the second quarter valued at $665,997,000. California State Teachers Retirement System raised its holdings in shares of National Health Investors by 7,748.8% in the 2nd quarter. California State Teachers Retirement System now owns 4,077,393 shares of the real estate investment trust’s stock worth $310,942,000 after purchasing an additional 4,025,444 shares in the last quarter. State Street Corp lifted its position in shares of National Health Investors by 5.0% during the 2nd quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock valued at $143,651,000 after acquiring an additional 95,812 shares during the last quarter. Principal Financial Group Inc. lifted its stake in National Health Investors by 2.0% during the first quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust’s stock valued at $137,537,000 after buying an additional 32,902 shares in the last quarter. Finally, Bank of New York Mellon Corp acquired a new stake in shares of National Health Investors during the second quarter valued at approximately $122,509,000. 62.51% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other National Health Investors news, Director Robert A. Mccabe, Jr. acquired 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average cost of $71.65 per share, with a total value of $63,768.50. Following the purchase, the director owned 44,159 shares in the company, valued at approximately $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 2.70% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.